Association between Branched-Chain amino acids and Epilepsy: A Mendelian randomized study

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• The link between branched-chain amino acids (BCAAs) and epilepsy is suggested but lacks definitive causal evidence.
• Understanding this relationship could offer novel therapeutic targets for epilepsy management.

Purpose of the Study:

• To investigate the causal relationship between BCAA levels and epilepsy using a robust genetic approach.
• To explore the specific roles of total BCAAs, leucine, isoleucine, and valine in epilepsy etiology.

Main Methods:

• Employed bidirectional Mendelian randomization (MR) analysis.
• Utilized genome-wide association study (GWAS) data for BCAA levels and epilepsy.
• Applied inverse variance-weighted (IVW) and MR-Egger methods with sensitivity analyses.

Main Results:

• Identified significant genetic variants for total BCAAs, leucine, isoleucine, and valine.
• Found a causal effect of total BCAA levels on epilepsy (OR=1.14, P=0.022).
• Demonstrated a causal effect of leucine levels on epilepsy (OR=1.15, P=0.025).

Conclusions:

• Established a causal link between elevated total BCAA and leucine levels with increased epilepsy risk.
• These findings provide new insights into the pathophysiological mechanisms of epilepsy.
• Suggests potential implications for epilepsy prevention and treatment strategies targeting BCAA metabolism.